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At the beginning of our study period patients were
offered either balloon valvuloplasty or surgery, thereby pos-
sibly constituting a selection bias. Accordingly, a large
number of patients were operated in recent times, restricting
the number of available data for long-term follow-up.C
H
DCONCLUSIONS
A policy of aortic valve repair in pediatric populations is
effective in postponing reintervention. The longevity of the
repair is shorter after cusp extension and when performed in
infants. Caution should be used when performing tricsupid-
ization and cusp extension of bicuspid valves because it can
be responsible for mortality related to occlusion of the
coronary ostia by patches.References
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Dr Kristine Guleserian (Dallas, Tex). Let me start by congrat-
ulating you and Dr Brizard and the rest of the Melbourne group for
the excellent presentation and the very well-written manuscript
that I had a chance to review before this presentation of your expe-
rience over the past 13 years with 142 patients. Thirty of those
patients were less than a year of age, and 13 were neonates who
had undergone aortic valve repair with 80% freedom from reinter-
vention at 7 years, and two-thirds—or 66%—with freedom from
intervention at 9 years.
This is certainly a challenging group of patients for whomwe all
would like to provide a very durable and safe repair to help delay
subsequent reintervention, whether it’s re-repair; Ross procedure;
aortic valve replacement; or, in rare instances, cardiac transplanta-
tion. And of course, primary aortic valve repair is always favorable
with a goal to recapitulate normal aortic anatomy and physiology;
however, this is not always possible, and cusp extension or leaflet
extension procedures often, along with tricuspidization, are
required.
Drs Polimenakos, Ilbawi, and the Chicago group published their
results with aortic cusp extension using selective tricuspidization
in infants and children with actuarial freedom from reintervention
of 97%, 71%, and 56% at 1, 5, and 10 years. So those are pretty
similar.
And Dr Bacha and the Boston group have shown very good in-
termediate results with surgical aortic valvuloplasty, 80% of which
incorporated pericardial cusp extension for children and adoles-
cents with aortic insufficiency and no more than really moderate
aortic stenosis with freedom from intervention of 72% at 5 years
and 54% at 7.5 years.
In your presentation you point out the potential shortcomings of
cusp extension with respect to the shorter longevity of repair, par-
ticularly in the infant subgroup, and the development of what we
are calling presumed myocardial ischemia in the subset of patients
with the adverse events that you just outlined. You therefore urge
caution when employing the techniques.
So I have several questions for you. Is it possible that earlier in
the experience there was a learning curve associated with doing
these repairs that resolved after learning to recognize these events?
Dr Yves d’Udekem (Parkville, Victoria, Australia). We had
a lot of discussion mainly between Christian Brizard and myself
about what we would do with these complications and we are
divided. He tends to believe that we should get away from this
technique for bicuspid valve. I tend to still do them for bicuspid
aortic valve.
I think that we have in our practice operations that carry dan-
gers, and it’s not because there are complications that we should
avoid them. It is important for us to realize that there is a risk ofrdiovascular Surgery c Volume 145, Number 2 467
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Ddeath after an operation; therefore, if you’re not comfortable to do
them, then you should avoid them. If you are comfortable to do
them, you should exercise caution so that these complications do
not arise. So I leave it to individual surgeons to decide what to do.
Dr Guleserian. I agree with that. My second question is, again,
since you’ve recognized these events, what specific things have
you changed in terms of the technique? Please comment about
the glutaraldehyde fixation of the pericardial patches. Has there
has been any change in that technique in this time period?
Dr d’Udekem. Regarding the techniques, I think that if you
have a bicuspid valve, you should make sure that the coaptation
of the 3 cusps is central and not eccentric or close to the wall—
that’s what precipitates the prolapse of the free edge of the leaflet
toward the sinus.
Regarding the level of preparation of the pericardium, we are
gentler now than in the past. We moved from 6 to 8 minutes prep-
aration with glutaraldehyde to 2 baths of 2minutes in a flat fashion,
in a special press that we have for the pericardium. And then we do
full rinsing. I believe it is very important is to have a rinsing with
magnesium chloride in the final solution because that detoxifies
the glutaraldehyde. It is apparently important.
Dr Guleserian. A lot of other groups have decreased the
amount of time of fixation from 10 to somewhere around 5 to 6
and added further modifications.
Not surprisingly in the infant patient group those patients
tended to have a shorter durability of their repairs. My last question
is: Do you have any insight on how to provide this particular sub-
group with a more durable repair over time, particularly if they are
undergoing tricuspidization?
Dr d’Udekem. I’m glad you asked this question. We’ve
reviewed specifically our experience with children aged<1 year
and we’ve been able to compare our experience with surgery ver-
sus balloon dilatation. In the present work we excluded those who
had balloon commissurotomy. But when we looked at the aortic
valve surgery that was done in neonates—I think we had a group
of about 130 patients with close to 80 of those patients younger
than age 1 year—the result was absolutely stunningly in favor of
surgery. The freedom from reoperation was far better in the
patients operated on using this technique. The frequent techniques
were debulking of the valve and creation of neocommissure for
unicuspid valve. We didn’t do just simple blade commissurotomy
and just stick the blade through the valve, we did some more
refined work.
Most interesting is that by the time of 10 years follow-up, 20%
of patients who had a balloon valvuloplasty only were free of
reintervention and of residual stenosis or regurgitation, whereas
40% of those who had surgery were still free of any reintervention
and any aortic valve disease. That’s a manuscript that’s coming up.
Dr Gerhard Ziemer (Chicago, Ill). You showed a picture of
your Thoratec patient. This was a pretty tall patient and you had
to resuscitate him early after surgery. Was this a case of valvular
insufficiency in aMarfan patient?Would you do this type of plastic
in a Marfan patient?
Dr d’Udekem. The only surgery that we perform today in
Marfan patients is aortic root valve-sparing procedure. During
the past 5 years, at least, we have been able to repair all of them
with the David procedure. The patient you saw in that picture
had a stenotic bicuspid aortic valve with quite thick myocardium.468 The Journal of Thoracic and Cardiovascular SurgDr Ziemer. And a bicuspid Marfan’s aortic valve, would you
reconstruct it?
Dr d’Udekem. I would tend to repair all of them, yes.
DrKhanhNguyen (New York, NY). In the group that developed
ischemia, I noticed that 1 sinus tends to be small. We encountered
a similar situation in the operating room and the diagnosis was
made by echo. The extended cusp seemed to close off the sinus.
The maneuver that we tried was to enlarge the sinus and the ische-
mia went away. If you see a patient with this particular finding,
would you try to do something like that to restore flow?
Dr d’Udekem.We didn’t think about enlarging the sinus. As all
of you know, there are a few articles about cusp extension tech-
nique, but this issue was not yet described. I think it’s important
that it’s written that this problem can happen so that surgeons can
do either what you’ve done, or what we’ve done, and prevent it.
Dr Nguyen. The neonatal group that had the complete 3-leaflet
extension—how many of them in your series?
Dr d’Udekem. The complete 3-leaflet extension was done in 35
patients.
Dr Nguyen. And did you find that technically it’s harder to do
because the valves tend to be thinner and the roots are very small?
Any tips on the technique to extend those valves in neonatal
patients?
Dr d’Udekem. In neonates younger than 1 year, we found out
that generally speaking the disease is predominantly stenotic and
we have to—to have a durable repair—increase the effective ori-
fice area. We’ve tried to repair stenotic bicuspid valve at age 1,
2, and 3 years by leaving them bicuspid and that usually fails.
So if we have a bicuspid valve in a child of that age, we make it
tricuspid. If we have a neonate with a unicuspid valve, then we
tend to put new commissures with 2 triangular patches and we
make the valve bicuspid. It’s difficult to change a unicuspid valve
into a tricuspid valve in a neonate, but it is possible. My colleague
Igor did that recently. It’s very small. We found it difficult. So we
just make it bicuspid.
Dr Giovanni Stellin (Padova, Italy). I would like to congratu-
late you and Christian Brizard for these excellent results. A 60%
freedom from reoperation is an excellent result.
One or 2 patients needed reoperation during the same hospital-
ization. I wonder whether your repair was successful in all pa-
tients, or if in some instance it wasn’t judged successful in the
operating room and you had to carry on with the valve
replacement?
Dr d’Udekem.What happens is that we look at the valve and we
make the decision between Ross procedure and valve repair in the-
ater. And that’s what we tell patients. So far we have not found that
echo allowsus to predict in advancewhether or notwe can do a repair.
The idea now is that if we have a 4- or 5-year old, we can almost
always repair the valve, and that’s the beauty of the cusp exten-
sions. It has to be really extremely thick, it has to be a block of
fibrosis with no mobility on the hinge point of the leaflets for
you not to be able to repair.
If the valve is extremely dysplastic in a 14-, 15-, or 16-year old,
our threshold now is lower just to do a Ross procedure, because it’s
the time of the patient’s life where you want them to be free for 10
or 20 years without any problems. And we don’t want to operate at
age 16 years and have them back during the middle of their early
university years for a second operation.ery c February 2013
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DDr Stellin.Was any attempt to repair a valve turned into a valve
replacement?
Dr d’Udekem. I cannot remember any second run when we did
a Ross procedure and sowe did repair in all the patients. There was
only 1 patient in whom we did a Ross procedure during the same
hospital stay. We have some second runs to readjust the valve a lit-
tle bit at times, but the end result once we started to do a repair was
a repair.
Dr Emile Bacha (New York, NY). You’re talking about 2 prob-
lems with your cusp extensions: first is the acute coronary ische-
mia problem, which I believe a lot of people know about; and
second is the worse long-term outcomes. However, you have an in-
herent selection bias here because usually if you’re doing a cusp
extension, by definition the anatomy is going to be worse. I
don’t think that’s what you’re saying. You’re not saying that we
shouldn’t do cusp extension.
What are you proposing for the very bad valves? What do you
suggest at this point in time? Are you suggesting new techniques?The Journal of Thoracic and CaDr d’Udekem. I think cusp extension technique is a good tech-
nique. I think it’s worthwhile to repair aortic valves using this tech-
nique. It has the advantage of postponing reintervention for a fairly
long time. And I think that in congenital disease we will see results
similar to those that were published from Saudi Arabia for rheu-
matic aortic valve disease—the longevity of the repair will be be-
tween 5 and 15 years. I believe that by the end of 15 years all of the
patients will go back for reoperation.
But I believe that it’s a benefit to wait so that a patient can grow
to adult size. You can typically never do a Ross procedure with an
inclusion technique in these young children who have stenotic
valve. If you can wait until they reach adult size to have a Ross pro-
cedure, I think you can do a good inclusion technique. My belief is
that proceeding this way is going to provide the best future for
these patients with very bad disease.
Dr Bacha. On the other hand, the best subset of patients on
whom to do a Ross procedure is children with aortic stenosis.
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